Spectral Diagnostics Revenue 2006-2019 | EDTXF
Spectral Diagnostics revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Spectral Diagnostics Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $3 |
| 2017 | $3 |
| 2016 | $3 |
| 2015 | $2 |
| 2014 | $3 |
| 2013 | $3 |
| 2012 | $3 |
| 2011 | $2 |
| 2010 | $3 |
| 2009 | $3 |
| 2008 | $3 |
| 2007 | $3 |
| Spectral Diagnostics Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q2 2019 | $1 |
| Q1 2019 | $0 |
| Q4 2018 | $1 |
| Q3 2018 | $0 |
| Q2 2018 | $0 |
| Q1 2018 | $1 |
| Q4 2017 | $1 |
| Q3 2017 | $1 |
| Q2 2017 | $1 |
| Q1 2017 | $1 |
| Q4 2016 | $1 |
| Q3 2016 | $1 |
| Q2 2016 | $1 |
| Q1 2016 | $1 |
| Q4 2015 | $1 |
| Q3 2015 | $1 |
| Q2 2015 | $1 |
| Q1 2015 | $1 |
| Q4 2014 | $1 |
| Q3 2014 | $1 |
| Q2 2014 | $1 |
| Q1 2014 | $1 |
| Q4 2013 | $1 |
| Q3 2013 | $1 |
| Q2 2013 | $1 |
| Q1 2013 | $1 |
| Q4 2012 | $1 |
| Q3 2012 | $1 |
| Q2 2012 | $1 |
| Q1 2012 | $1 |
| Q4 2011 | $1 |
| Q3 2011 | $1 |
| Q2 2011 | $1 |
| Q1 2011 | $1 |
| Q4 2010 | $1 |
| Q3 2010 | $1 |
| Q2 2010 | $1 |
| Q1 2010 | $1 |
| Q4 2009 | $1 |
| Q3 2009 | $1 |
| Q2 2009 | $1 |
| Q1 2009 | $1 |
| Q4 2008 | $1 |
| Q3 2008 | $1 |
| Q2 2008 | $1 |
| Q1 2008 | $1 |
| Q4 2007 | $1 |
| Q3 2007 | $1 |
| Q2 2007 | $1 |
| Q1 2007 | $1 |
| Q3 2006 | $1 |
| Q2 2006 | $1 |
| Q4 2005 | $1 |
| Q3 2005 | $2 |
| Q2 2005 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.066B | $0.003B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $119.202B | 25.40 |
| Intuitive Surgical (ISRG) | United States | $60.303B | 52.74 |
| Edwards Lifesciences (EW) | United States | $45.649B | 44.43 |
| IDEXX Laboratories (IDXX) | United States | $22.854B | 57.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.053B | 14.13 |
| Olympus (OCPNY) | Japan | $18.002B | 0.00 |
| Teleflex (TFX) | United States | $15.310B | 32.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.143B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $13.974B | 37.67 |
| DexCom (DXCM) | United States | $13.337B | 197.65 |
| Hologic (HOLX) | United States | $13.290B | 20.98 |
| STERIS (STE) | Ireland | $12.205B | 28.15 |
| Varian Medical Systems (VAR) | United States | $10.690B | 25.58 |
| ABIOMED (ABMD) | United States | $8.459B | 48.42 |
| Masimo (MASI) | United States | $8.054B | 48.87 |
| SARTORIUS AG (SARTF) | Germany | $6.158B | 54.71 |
| Integra LifeSciences Holdings (IART) | United States | $5.252B | 23.43 |
| Penumbra (PEN) | United States | $5.184B | 186.25 |
| Elekta AB (EKTAY) | Sweden | $5.142B | 39.59 |
| Globus Medical (GMED) | United States | $5.066B | 32.15 |
| LivaNova (LIVN) | United Kingdom | $4.122B | 31.43 |
| Cantel Medical (CMD) | United States | $3.630B | 36.82 |
| Tandem Diabetes Care (TNDM) | United States | $3.605B | 0.00 |
| Nevro (NVRO) | United States | $2.779B | 0.00 |
| Glaukos (GKOS) | United States | $2.693B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.648B | 232.22 |
| Integer Holdings (ITGR) | United States | $2.527B | 17.87 |
| Nihon Kohden (NHNKY) | Japan | $2.457B | 24.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.825B | 33.86 |
| OPKO Health (OPK) | United States | $1.336B | 0.00 |
| Veracyte (VCYT) | United States | $1.247B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.116B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.114B | 0.00 |
| CryoLife (CRY) | United States | $1.109B | 105.61 |
| Inogen (INGN) | United States | $1.062B | 26.03 |
| Natus Medical (NTUS) | United States | $1.056B | 24.60 |
| Luminex (LMNX) | United States | $1.018B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.992B | 122.61 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.972B | 30.53 |
| Mesa Laboratories (MLAB) | United States | $0.929B | 42.90 |
| Corindus Vascular Robotics (CVRS) | United States | $0.887B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.850B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.692B | 22.55 |
| Quotient (QTNT) | Switzerland | $0.581B | 0.00 |
| Intersect ENT (XENT) | United States | $0.577B | 0.00 |
| AxoGen (AXGN) | United States | $0.563B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| Si-Bone (SIBN) | United States | $0.464B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.376B | 14.44 |
| ViewRay (VRAY) | United States | $0.375B | 0.00 |
| Fluidigm (FLDM) | United States | $0.373B | 0.00 |
| Sientra (SIEN) | United States | $0.350B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.345B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.336B | 0.00 |
| Accuray (ARAY) | United States | $0.269B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.266B | 45.00 |
| IRadimed (IRMD) | United States | $0.262B | 43.47 |
| SeaSpine Holdings (SPNE) | United States | $0.241B | 0.00 |
| Stereotaxis (STXS) | United States | $0.241B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.241B | 36.22 |
| CRH Medical (CRHM) | Canada | $0.215B | 74.50 |
| Neuronetics (STIM) | United States | $0.209B | 0.00 |
| TransEnterix (TRXC) | United States | $0.165B | 0.00 |
| ConforMIS (CFMS) | United States | $0.136B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.128B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.118B | 58.29 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.105B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.071B | 0.00 |
| Vermillion (VRML) | United States | $0.062B | 0.00 |
| Electromed (ELMD) | United States | $0.052B | 26.74 |
| Helius Medical Technologies (HSDT) | United States | $0.050B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.043B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.038B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.033B | 0.00 |
| Neovasc (NVCN) | Canada | $0.030B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.026B | 0.00 |
| Nuvectra (NVTR) | United States | $0.025B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.023B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.25 |
| Lianluo Smart (LLIT) | China | $0.013B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.011B | 0.00 |
| Dynatronics (DYNT) | United States | $0.011B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Micron Solutions (MICR) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.004B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.004B | 0.00 |
